SAN FRANCISCO, July 22, 2024 /PRNewswire/ -- Invitae (OTC: NVTAQ), a leading medical genetics company, today announced the launch of its Unlock™ Behind the Seizure ® program, which provides accessible ...
SAN FRANCISCO, Feb. 26, 2019 /PRNewswire/ -- As Rare Disease Day focuses attention on the challenges of diagnosing rare, often genetic conditions, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Invitae ...
BioMarin Pharmaceutical and Invitae are expanding their free genetic testing program for children with seizures. Now through the Behind the Seizure initiative, any child under the age of five who has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback